Codexis vs LanzaTech Global
CDXS and LNZA side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CDXS and LNZA compare
Codexis is the larger company, worth 1.9 times as much as LanzaTech Global ($130M against $67.1M).
LanzaTech Global grew revenue faster over the last twelve months (43.8% versus 35.9% for Codexis).
LanzaTech Global keeps more of each dollar of sales as profit, with a net margin of 296% compared with −39.6% at Codexis.
LanzaTech Global scores higher on the StockData Score (12 against 5 for Codexis), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CDXS | LNZA |
|---|---|---|
| Size and price | ||
| Market cap | $130M | $67.1M |
| Share price | $1.19 | $5.13 |
| Change, 1 year | −50.8% | −78.0% |
| Change, 5 years | −97.0% | −99.5% |
| Beta (5Y) | 2.41 | 1.02 |
| Employees | 146 | 192 |
| StockData Score | ||
| Total score | 5 | 12 (better) |
| Valuation score | 1 | 2 (better) |
| Growth score | 2 | 2 |
| Performance score | 1 | 3 (better) |
| Health score | 1 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 0.3× |
| P/S | 1.7× | 1.2× (better) |
| P/B | 4.0× | 0.3× (better) |
| FCF yield | −9.3% (better) | −50.3% |
| Fair value | $1.22 | – |
| Margin of safety | 2.1% | – |
| Growth | ||
| Revenue growth (TTM) | 35.9% | 43.8% (better) |
| Revenue growth, 5Y average | 0.38% | – |
| Profitability | ||
| Gross margin | 87.0% | – |
| Operating margin | −35.6% (better) | −61.0% |
| Net margin | −39.6% | 296% (better) |
| FCF margin | −15.7% (better) | −58.0% |
| Return on equity | −69.4% | 146% (better) |
| Return on invested capital | −91.8% | −37.2% (better) |
| Financial health | ||
| Debt / equity | 1.24 (better) | 0.00 |
| Current ratio | 3.06 (better) | 2.48 |
| Altman Z-score | −6.05 | −3.06 (better) |
| Piotroski F-score | 4 (better) | 3 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 63.7% | 25.4% |
| Held by insiders | 2.2% | – |
| Insider net buying, 12 months | −$7.6M | $4.3M (better) |
| Short interest, % of float | 4.5% | – |
Go deeper
- CDXS stock overview
- CDXS income statement
- CDXS valuation and score
- LNZA stock overview
- LNZA income statement
- LNZA valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.